<https://archive-ouverte.unige.ch/unige:37154#id>	<http://id.loc.gov/vocabulary/relators/aut>	<http://www.idref.fr/267507410/id> .
<https://archive-ouverte.unige.ch/unige:37154#id>	<http://id.loc.gov/vocabulary/relators/aut>	<http://www.idref.fr/076644243/id> .
<https://archive-ouverte.unige.ch/unige:37154#id>	<http://id.loc.gov/vocabulary/relators/aut>	<http://www.idref.fr/230483798/id> .
<https://archive-ouverte.unige.ch/unige:37154#id>	<http://id.loc.gov/vocabulary/relators/aut>	<http://www.idref.fr/034966293/id> .
<https://archive-ouverte.unige.ch/unige:37154#id>	<http://purl.org/dc/elements/1.1/date>	"2013" .
<https://archive-ouverte.unige.ch/unige:37154#id>	<http://purl.org/dc/terms/bibliographicCitation>	"Tanguy-Schmidt Aline, Rousselot Philippe, Chalandon Yves, Cayuela Jean-Michel, Hayette Sandrine, Vekemans Marie-Christiane, Escoffre Martine, Huguet Fran\u00E7oise, R\u00E9a Delphine, Delannoy Andr\u00E9, Cahn Jean-Yves, Vernant Jean-Paul, Ifrah Norbert, Dombret Herv\u00E9, Thomas Xavier. Long-term follow-up of the imatinib GRAAPH-2003 study in newly diagnosed patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia: a GRAALL study. 2013." .
<https://archive-ouverte.unige.ch/unige:37154#id>	<http://purl.org/ontology/bibo/doi>	"10.1016/j.bbmt.2012.08.021" .
<https://archive-ouverte.unige.ch/unige:37154#id>	<http://id.loc.gov/vocabulary/relators/aut>	<http://www.idref.fr/092865208/id> .
<https://archive-ouverte.unige.ch/unige:37154#id>	<http://id.loc.gov/vocabulary/relators/aut>	<http://www.idref.fr/059320931/id> .
<https://archive-ouverte.unige.ch/unige:37154#id>	<http://id.loc.gov/vocabulary/relators/aut>	<http://www.idref.fr/034380736/id> .